| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $2.41 (Beat by $0.01) |
| EPS GAAP Actual | $2.41 (Beat by $0.01) |
| Revenue Actual | $21.957B |
| Revenue Surprise | Beat by $21957M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 19.1739 | 10.29 | 18.75627 | 19.80271 | 3 |
| Dec 2028 | 16.79 | 11.76 | 16.38047 | 17.25551 | 7 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.42 | 2.42 | 21.957B | 96.81% | 21957M |
| FQ2 2025 (Jun 2025) | 2.84 | 2.84 | 21.132B | 6.44% | 21132M |
| FQ1 2025 (Mar 2025) | 2.59 | 2.59 | 20.886B | 6.19% | 20886M |
| FQ4 2024 (Dec 2024) | 2.55 | 2.55 | 21.872B | 6.37% | 21872M |
| FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 0.701B | -2646.36% | 701M |
| FQ2 2024 (Jun 2024) | 2.5 | 2.5 | 19.772B | 2.91% | 19772M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 19.594B | -0.19% | 19594M |
| FQ4 2023 (Dec 2023) | 1.74 | 1.74 | 20.478B | 1% | 20478M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.3393 | -- | 3.22031 | 3.39958 | 5 |
| FQ3 2027 (Sep 2027) | 3.5899 | -- | 3.46198 | 3.6547 | 3 |
| FQ2 2027 (Jun 2027) | 3.48903 | -- | 3.3647 | 3.55201 | 5 |
| FQ1 2027 (Mar 2027) | 3.30363 | -- | 3.18591 | 3.36327 | 3 |
| FQ4 2026 (Oct 2026) | 3.07 | -- | 2.98806 | 3.14854 | 9 |
| FQ3 2026 (Jul 2026) | 3.06 | 20.92 | 2.97832 | 3.13828 | 9 |
| FQ2 2026 (Jun 2026) | 2.9085 | 2.36 | 2.80486 | 2.961 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 26.2B | -- | 25.48B | 26.56B | 3 |
| FQ3 2027 (Sep 2027) | 24.32B | -- | 23.65B | 24.66B | 3 |
| FQ2 2027 (Jun 2027) | 23.99B | -- | 23.33B | 24.32B | 3 |
| FQ1 2027 (Mar 2027) | 24.1B | -- | 23.44B | 24.43B | 3 |
| FQ4 2026 (Oct 2026) | 20.51B | -- | 20.09B | 20.91B | 8 |
| FQ3 2026 (Jul 2026) | 20.36B | -7.83 | 19.94B | 20.76B | 5 |
| FQ2 2026 (Jun 2026) | 23.08B | 8.42 | 22.44B | 23.4B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.42 | 2.42 | 100% | |
| FQ2 2025 (Jun 2025) | 2.84 | 2.84 | 100% | |
| FQ1 2025 (Mar 2025) | 2.59 | 2.59 | 100% | |
| FQ4 2024 (Dec 2024) | 2.55 | 2.55 | 100% | |
| FQ3 2024 (Sep 2024) | 2.62 | 2.62 | 100% | |
| FQ2 2024 (Jun 2024) | 2.5 | 2.5 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 1.74 | 1.74 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $21.96B | $21957M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $21.13B | $21132M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $20.89B | $20886M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $21.87B | $21872M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.7B | $701M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $19.77B | $19772M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $19.59B | $19594M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $20.48B | $20478M | 100% |